Does RUXOLITINIB Cause Rectal haemorrhage? 109 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 109 reports of Rectal haemorrhage have been filed in association with RUXOLITINIB (OPZELURA). This represents 0.2% of all adverse event reports for RUXOLITINIB.
109
Reports of Rectal haemorrhage with RUXOLITINIB
0.2%
of all RUXOLITINIB reports
16
Deaths
63
Hospitalizations
How Dangerous Is Rectal haemorrhage From RUXOLITINIB?
Of the 109 reports, 16 (14.7%) resulted in death, 63 (57.8%) required hospitalization, and 7 (6.4%) were considered life-threatening.
Is Rectal haemorrhage Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 109 reports have been filed with the FAERS database.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Rectal haemorrhage?
RIVAROXABAN (4,501)
ASPIRIN (3,057)
ADALIMUMAB (2,629)
VEDOLIZUMAB (2,163)
INFLIXIMAB (1,554)
CLOPIDOGREL BISULFATE (1,333)
APIXABAN (1,177)
WARFARIN (1,174)
PREDNISONE (1,098)
MESALAMINE (990)
Which RUXOLITINIB Alternatives Have Lower Rectal haemorrhage Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE